Pharmacist Culture Review in Urgent Care: Two Hours Faster, Similar Revisits
This single-system retrospective cohort tests whether infectious diseases and emergency medicine pharmacists operating under a collaborative practice agreement can match or beat clinician review of urgent care microbiology results.
📅 Journal publication: Aug 2026·Last updated: Nov 9, 2026
Pharmacists speed up urgent care treatment decisions by 2 hours.
Pharmacist-driven microbiology review programs can potentially improve antimicrobial treatment in urgent care settings. The program reduced the time to appropriate treatment by 2 hours compared to physician-only reviews (11 hours vs 13 hours, p = 0.047), with similar unplanned 30-day revisit rates. This study supports integrating pharmacists into urgent care teams to enhance timely treatment; however, the difference was small and revisit rates were unchanged. Pharmacist-driven reviews may marginally speed up appropriate treatment without impacting revisit rates.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Bomkamp JP, Craft BV, Nuest H, Bjornstad M, Slavens J
Citation:Bomkamp JP, Craft BV, Nuest H, et al. A Retrospective Evaluation of a Pharmacist-Driven Urgent Care Microbiology Review Program. Journal of the American College of Clinical Pharmacy : JACCP. 2026;9(8):e70262. doi:10.1002/jac5.70262